Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.

Leukemia - 1 Aug 2017

Maslah N, Cassinat B, Verger E, Kiladjian J-J, Velazquez L

Abstract excerpt

Malignant hematological diseases are mainly because of the occurrence of molecular abnormalities leading to the deregulation of signaling pathways essential for precise cell behavior. High-resolution genome analysis using microarray and large-scale sequencing have helped identify several important acquired gene mutations that are responsible for such signaling deregulations across different hematological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Hematologic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to Intracellular Signaling Peptides and Proteins

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Polycythemia

Share to Proteins

Source

Identifiers

PMID: 28484264
DOI: 10.1038/leu.2017.139

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.PMID 28484264Read ↗

[Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].Semantic proximity Read ↗

The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.Semantic proximity Read ↗

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasmsSemantic proximity Read ↗

Germline bi-allelic SH2B3/LNK alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder.Semantic proximity Read ↗

Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.Semantic proximity Read ↗

LNK mutations and myeloproliferative disorders.Semantic proximity Read ↗

LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation.Semantic proximity Read ↗

Disease-specific mutations in mature lymphoid neoplasms: recent advances.Semantic proximity Read ↗

SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.Semantic proximity Read ↗

New pieces of a puzzle: the current biological picture of MPN.Semantic proximity Read ↗

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b.Semantic proximity Read ↗

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.